Michael A Weber

Global burden of cardiovascular disease and stroke: hypertension at the core.

D. Lackland, Michael A. Weber, Daniel T Lackland, 2015, The Canadian journal of cardiology.

Endovascular ultrasound renal denervation to treat hypertension (RADIANCE-HTN SOLO): a multicentre, international, single-blind, randomised, sham-controlled trial

Neil Chapman, Manish Saxena, Jai Radhakrishnan, 2018, The Lancet.

Principal results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) trial.

Peter Sleight, Janet Wittes, James D Neaton, 2003, JAMA.

When and how to use self (home) and ambulatory blood pressure monitoring.

Thomas G Pickering, William B White, Suzanne Oparil, 2010, Journal of the American Society of Hypertension : JASH.

Blood pressure variability and risk of cardiovascular events and death in patients with hypertension and different baseline risks

Giuseppe Mancia, Gianfranco Parati, Knut Liestøl, 2018, European heart journal.

Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events.

Patrice Cacoub, Eric J Topol, Werner Hacke, 2006, The New England journal of medicine.

Critical issues in peripheral arterial disease detection and management: a call to action.

Eric J Topol, Robert M Califf, Peter Hanrath, 2003, Archives of internal medicine.

Efficacy and safety of nebivolol and valsartan as fixed-dose combination in hypertension: a randomised, multicentre study

Wei Chen, J. Basile, T. Giles, 2014, The Lancet.

Antihypertensive efficacy of hydrochlorothiazide vs chlorthalidone combined with azilsartan medoxomil.

W. Cushman, G. Bakris, W. White, 2012, The American journal of medicine.

Catheter-based renal denervation in patients with uncontrolled hypertension in the absence of antihypertensive medications (SPYRAL HTN-OFF MED): a randomised, sham-controlled, proof-of-concept trial

Neil Chapman, Michael Böhm, Kazuomi Kario, 2017, The Lancet.